-The Hindu Study raises safety, efficacy concerns; call for ban of irrational formulations Of the 110 anti-TB (tuberculosis) Fixed Dose Combinations (FDCs) available in India, only 32 (less than 30%) have been approved by the Central Drugs Standard Control Organisation (CDSCO), the country’s drug regulator. In the case of malaria FDCs, only eight out of 20 (40%), have been approved. These statistics, that give rise to safety and efficacy concerns, have been brought...
More »SEARCH RESULT
Total Matching Records found : 55
Last-resort antibiotic sales jump -GS Mudur
-The Telegraph New Delhi: The sale of drug combinations containing last-resort antibiotics is rising faster than overall antibiotics sales in India, health researchers have said in a study that also highlights the government's failure to stop the sale of irrational and unapproved antibiotic cocktails. While total antibiotics sales in India rose 26 per cent over a four-year period, says the study, there was a 174 per cent increase in the sales of...
More »Can doctors judge best quality in medicines? -Jyotsna Singh
-The Hindu Doctors’ objections to prescribing medicines by generic names fly in the face of a recent report on substandard drugs In a surprise move on April 17, Prime Minister Narendra Modi announced that his government will soon make it mandatory for doctors to prescribe medicines by generic names. The decision was to ensure drug prices remain affordable and patients get a wider bouquet of options instead of being forced to...
More »Cheap generic vs costly branded: Issues in picking right drug in India -Kaunain Sheriff M
-The Indian Express Prime Minister Narendra Modi wants doctors to prescribe generic medicines over branded ones. KAUNAIN SHERIFF M answers key questions on the pricing of drugs and beyond. * What exactly has Prime Minister Narendra Modi said on generic drugs? Speaking in Surat on April 17, the Prime Minister referred to the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP), which aims to provide cheaper medical drugs to the people. “In the coming days,...
More »Not consulted on scrapping drug pricing agency: Chairman -Vidya Krishnan
-The Hindu New Delhi: Days after it was revealed that the Centre is likely to dismantle the National Pharmaceutical Pricing Agency (NPPA), its chairman said the decision was ‘rushed’ and the agency was not consulted. “There were two meetings and the NPPA was not a party to them. Both meetings were held at short notice. This has been a rushed decision. For any policy change, there needs to be consultation. I understand...
More »
